Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Biotechnologyβ
2026-07-06KROS3Power of Attorney for Keros Therapeutics, Inc. - Anne PrenerMEDIUM
This filing details a Power of Attorney granted by Anne Prener, a director of Keros Therapeutics, Inc. (KROS), to Jasbir Seehra, Keith Regnante, and Esther Cho. The attorneys-in-fact are authorized to execute and submit Forms 3, 4, and 5 to the SEC on behalf of Ms. Prener, as required by Section 16(a) of the Securities...
Micro CapBiotechnology
2026-07-06BYSI3Initial Statement of Beneficial Ownership of Securities - BeyondSpring Inc.
This filing reports an initial statement of beneficial ownership of securities for Li Na (NL), Chief Financial Officer of BeyondSpring Inc. (BYSI). The report covers the period ending July 1, 2026. Li Na is identified with reporting owner ID CIK 0002143656 and resides in Florham Park, NJ. The filing indicates that ther...
Nano CapBiotechnology